Hayman, Erik G.
Wessell, Aaron
Gerzanich, Volodymyr
Sheth, Kevin N.
Simard, J. Marc
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS060801, NS061808)
National Heart, Lung, and Blood Institute (HL082517)
Article History
First Online: 19 December 2016
Compliance with Ethical Standards
:
: Dr. Simard holds a US patent (7,285,574), a novel non-selective cation channel in neural cells and methods for treating brain swelling. Dr. Simard is a member of the scientific advisory board and holds shares in Remedy Pharmaceuticals. No support, direct or indirect, was provided to Dr. Simard, or for this project, by Remedy Pharmaceuticals. All other authors report no conflicts.